|
货号
|
品名
|
CAS No.
|
分子式
|
包装规格
|
应用
|
|
T350050
|
2-Thio-2’-deoxy Cytidine
|
169557-13-5
|
C9H13N3O3S
|
10/100mg
|
2-含硫吡啶核苷
|
|
D230625
|
Delavirdine
|
136817-59-9
|
C22H28N6O3S
|
10/100mg
|
BHAP逆转录酶抑制剂
|
|
D230630
|
Delavirdine Mesylate
|
147221-93-0
|
C23H32N6O6S2
|
10/100mg
|
BHAP逆转录酶抑制剂
|
|
D528800
|
Dolutegravir
|
1051375-16-6
|
C20H19F2N3O5
|
2.5/25mg
|
Dolutegravir分析标准品
|
|
I525000
|
Indinavir Sulfate
|
157810-81-6
|
C36H49N5O8S
|
5/50mg
|
Hiv -1蛋白酶抑制剂
|
|
I525001
|
Indinavir
|
150378-17-9
|
C36H49N5O8S
|
10/100mg
|
Hiv – 1蛋白酶抑制剂
|
|
N391275
|
Nevirapine
|
129618-40-2
|
C15H14N4O
|
5/50/250mg
|
hiv – 1强有力的(IC50 = 84 nm)和选择性非核苷逆转录酶抑制剂
|
|
N389750
|
Nelfinavir Mesylate
|
159989-65-8
|
C33H49N3O7S2
|
10/100mg
|
HIV蛋白酶抑制剂
|
|
C633150
|
Cobicistat
|
1004316-88-4
|
C40H53N7O5S2
|
10/25/50mg
|
HIV蛋白酶抑制剂
|
|
P681025
|
Podorhizol β-D-Glucopyranoside
|
17187-73-4
|
C28H34O13
|
2.5/25mg
|
Podorhizol β-D-吡喃葡萄糖苷，抗病毒剂
|
|
A607897
|
(2S,3S,5S)-5-Amino-1,6-diphenyl-2-([[thiazol-5-ylmethoxy)carbonyl]amino]hexan-3-yl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate Hydrochloride-d6
|
|
C37H43D6ClN6O5S2
|
0.5/5mg
|
Ritonavor前体
|
|
D201750
|
3-Deazaneplanocin A
|
120964-45-6
|
C12H15ClN4O3
|
1/5/10mg
|
S-adenosylhomocysteineydrolase水解酶抑制剂
|
|
C982175
|
3-Cyano-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4-triazole
|
40371-99-1
|
C14H16N4O7
|
25/250mg
|
Viramidine 衍生物
|
|
A105015
|
ent-Abacavir
|
136470-79-6
|
C14H18N6O
|
5/50mg
|
阿巴卡韦对映体，核苷逆转录酶抑制剂
|
|
A192450
|
Acyclovir N-Methylene Dimer
|
|
C17H22N10O6
|
1/10mg
|
阿昔洛韦二聚杂质
|
|
F696850
|
4-Formyl Antipyrine
|
950-81-2
|
C12H12N2O2
|
2.5/25g
|
安替比林衍生物
|
|
O239020
|
Octaverine Hydrochloride
|
6775-26-4
|
C23H28ClNO5
|
10/100mg
|
奥他维林盐酸盐分析标准品
|
|
T662400
|
3’’-O-Tosyl Entecavir
|
|
C19H21N5O5S
|
5/50mg
|
保护的恩替卡韦
|
|
N389752
|
Nelfinavir-d3
|
|
C32H42D3N3O4S
|
1/10mg
|
标记的HIV蛋白酶抑制剂
|
|
L379002
|
Levovirin -13C5
|
|
C313C5H12N4O5
|
0.5/5mg
|
标记的Levovirin类似物
|
|
A634402
|
Amprenavir-d4
|
|
C25H31D4N3O6S
|
1/10mg
|
标记的安普那韦
|
|
F696852
|
4-Formyl Antipyrine-d3
|
|
C12H9D3N2O2
|
5/50mg
|
标记的安替比林衍生物
|
|
G235022
|
Ganciclovir Mono-O-propionate-d5
|
|
C12H12D5N5O5
|
1/10mg
|
标记的更昔洛韦Mono-O-丙酸酯类似物。是更昔洛韦潜在的前体。抗病毒剂。
|
|
M526802
|
2’-Monodehydroxy-2’-chloro Ganciclovir-d5
|
|
C9H7D5ClN5O3
|
1/10mg
|
标记的更昔洛韦杂质
|
|
B190250
|
Benzethonium Chloride
|
121-54-0
|
C27H42ClNO2
|
10/100g
|
标记的合成的季铵盐具有表面活性剂、杀菌和抗感染的特性
|
|
B190252
|
Benzethonium-d7 Chloride
|
|
C27H35D7ClNO2
|
5/50mg
|
标记的合成的季铵盐具有表面活性剂、杀菌和抗感染的特性
|
|
L172502
|
Lamivudine-15N2,13C
|
|
C713CH11N15N2O3S
|
1/10mg
|
标记的拉米夫定
|
|
E588527
|
5’-Epi Lamivudine-15N2,13C
|
|
C713CH11N15N2O3S
|
0.5/5mg
|
标记的拉米夫定差向异构体
|
|
R414477
|
Ribavirin-13C5
|
|
C313C5H12N4O5
|
1/10mg
|
标记的利巴韦林
|
|
D297432
|
Desthiazolylmethyloxycarbonyl Ritonavir-d6
|
|
C32H39D6N5O3S
|
1/10mg
|
标记的利托那韦代谢物
|
|
R701692
|
(5R)-Rupintrivir-d3
|
|
C31H36D3FN4O7
|
0.25/2.5mg
|
标记的芦平曲韦5R-enantiomer
|
|
N391277
|
Nevirapine-d5 See N391278
|
|
C15H9D5N4O
|
1/10mg
|
标记的奈韦拉平
|
|
N391278
|
Nevirapine-d3
|
1051419-24-9
|
C15H11D3N4O
|
2.5/25mg
|
标记的奈韦拉平
|
|
H948627
|
2-Hydroxy Nevirapine-d3
|
|
C15H11D3N4O2
|
1/10mg
|
标记的奈韦拉平代谢物
|
|
H948632
|
3-Hydroxy Nevirapine-d3
|
|
C15H11D3N4O2
|
0.5/5mg
|
标记的奈韦拉平代谢物
|
|
P580352
|
Pleconaril-d8 (Major)
|
1346602-36-5
|
C18H10D8F3N3O3
|
1/10mg
|
标记的普拉康纳利，小核糖核酸病毒复制抑制剂，抗病毒。
|
|
S135002
|
Saquinavir-d9
|
1356355-11-7
|
C38H41D9N6O5
|
1/10mg
|
标记的沙奎那韦
|
|
S135003
|
Saquinavir-d6
|
|
C38H44D6N6O5
|
10mg
|
标记的沙奎那韦
|
|
E425002
|
rac Efavirenz-d4 Also see: E425003
|
|
C14H5D4ClF3NO2
|
1/10mg
|
标记的依法韦仑
|
|
E425003
|
rac Efavirenz-d5 (major)
|
|
C14H4D5ClF3NO2
|
0.5/5mg
|
标记的依法韦仑
|
|
D232945
|
2’-Deoxy-2’-fluoro Cytidine
|
10212-20-1
|
C9H12FN3O4
|
100mg/1g
|
丙型肝炎次基因组强有力抑制剂
|
|
E558900
|
Entecavir
|
142217-69-4
|
C12H15N5O3
|
10/100mg
|
恩替卡韦
|
|
H946555
|
9-((1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-2-(2-oxo-2-phenylethyl)-1H-purin-6(9H)-one
|
|
C19H19N5O4
|
5mg
|
恩替卡韦苯甲酰保护衍生物，抗病毒
|
|
E558920
|
1’-epi-Entecavir
|
|
C12H15N5O3
|
10/25mg
|
恩替卡韦差向异构体杂质
|
|
E558925
|
3’-epi-Entecavir
|
|
C12H15N5O3
|
10/25mg
|
恩替卡韦差向异构体杂质
|
|
E558930
|
4’-epi-Entecavir
|
1367369-80-9
|
C12H15N5O3
|
2.5/25mg
|
恩替卡韦差向异构体杂质
|
|
H946560
|
9-((1S,3R,4S)-4-Hydroxy-3-(((4-methoxyphenyl)diphenylmethoxy)methyl)-2-methylenecyclopentyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-6(9H)-one
|
|
C52H47N5O5
|
10/100mg
|
恩替卡韦差向异构体杂质
|
|
H946565
|
9-((1S,3R,4R)-4-Hydroxy-3-(((4-methoxyphenyl)diphenylmethoxy)methyl)-2-methylenecyclopentyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-6(9H)-one
|
|
C52H47N5O5
|
2.5/25mg
|
恩替卡韦差向异构体杂质
|
|
M266070
|
(1S,2R,4S)-2-(((4-Methoxyphenyl)diphenylmethoxy)methyl)-4-(2-(((4-methoxyphenyl)diphenylmethyl)amino)-6-oxo-1H-purin-9(6H)-yl)-3-methylenecyclopentyl 4-nitrobenzoate
|
|
C59H50N6O8
|
5/50mg
|
恩替卡韦差向异构体杂质
|
|
E558905
|
ent-Entecavir
|
188399-46-4
|
C12H15N5O3
|
1/10mg
|
恩替卡韦对映体杂质
|
|
D417552
|
3’,5’-Di-O-benzyl Entecavir-13C2,15N
|
|
C2413C2H27N415NO3
|
0.5/5mg
|
恩替卡韦对映体中间体
|
|
M263075
|
(1R,2R,3R,5R)-5-[(4-Methoxyphenyl)-diphenylmethylamino-6-bezyloxy-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-cyclopentanol
|
|
C52H49N5O5
|
2.5/25mg
|
恩替卡韦对映体中间体
|
|
M263080
|
2-N-[(4-Methoxyphenyl)-diphenylmethyl]-4,6’-O-dibenzyl ent-Entecavir
|
1354695-79-6
|
C53H49N5O4
|
1/10mg
|
恩替卡韦对映体中间体
|
|
D417550
|
3’,5’-Di-O-benzyl Entecavir
|
142217-81-0
|
C26H27N5O3
|
25/250mg
|
恩替卡韦对映体中间体
|
|
E558935
|
(1R,3R,4R)-Entecavir
|
1367369-76-3
|
C12H15N5O3
|
10/25/50mg
|
恩替卡韦同分异构体杂质
|
|
H939670
|
8-Hydroxy Entecavir
|
|
C12H15N5O4
|
10/25mg
|
恩替卡韦杂质
|
|
D417150
|
3’,5’-Di-O-benzoyl Fialuridine (1:3 α/β Mixture)(see D417160)
|
|
C23H18FIN2O7
|
25/250mg
|
非阿尿苷中间体
|
|
D417160
|
3’,5’-Di-O-benzoyl Fialuridine
|
97614-45-4
|
C23H18FIN2O7
|
25/250mg
|
非阿尿苷中间体
|
|
C365545
|
6-Chloro-2-cyclopropyl-4-(trifluoromethyl)-quinoline
|
391860-73-4
|
C13H9ClF3N
|
500mg/5g
|
非核苷hiv – 1逆转录酶抑制剂。
|
|
E425000
|
Efavirenz
|
154598-52-4
|
C14H9ClF3NO2
|
10/100mg
|
非核苷hiv – 1逆转录酶抑制剂。
|
|
G235020
|
Ganciclovir Mono-O-propionate
|
194159-18-7
|
C12H17N5O5
|
50/500mg
|
更昔洛韦Mono-O-丙酸酯类似物。是更昔洛韦潜在的前体。抗病毒剂。
|
|
G235030
|
Ganciclovir Triphosphate
|
86761-38-8
|
C9H16N5O13P3
|
1/10mg
|
更昔洛韦三磷酸盐
|
|
M526800
|
2’-Monodehydroxy-2’-chloro Ganciclovir
|
108436-36-8
|
C9H12ClN5O3
|
50/500mg
|
更昔洛韦杂质
|
|
C379785
|
9-[[2-chloroprop-2-en-1-yl)oxy]methyl]guanine
|
|
C9H10ClN5O2
|
25/50/100mg
|
更昔洛韦杂质
|
|
F335002
|
Fialuridine-15N2,13C
|
|
C813CH10FI15N2O5
|
10/25mg
|
核苷类似物
|
|
N389765
|
Nelfinavir Sulfone
|
1041389-29-0
|
C32H45N3O6S
|
10/100mg
|
甲磺酸奈非那韦杂质
|
|
N389770
|
Nelfinavir Sulfoxide
|
1041389-28-9
|
C32H45N3O5S
|
10/100mg
|
甲磺酸奈非那韦杂质
|
|
P838335
|
2-Propyltriphenylphosphonium Bromide
|
1530-33-2
|
C21H22BrP
|
100mg/1g
|
具有抗病毒活性
|
|
P681000
|
Podophyllotoxin
|
518-28-5
|
C22H22O8
|
500mg/5g
|
抗HPVs剂
|
|
R414475
|
Ribavirin
|
36791-04-5
|
C8H12N4O5
|
100mg/250mg/1g
|
抗病毒剂
|
|
E425010
|
Efavirenz Pen-3-ene-1-yne(cis/trans Mixture)
|
|
C14H9ClF3NO2
|
2.5/25mg
|
抗病毒剂
|
|
E555600
|
Enfuvirtide Acetate
|
914454-00-5
|
C206H305N51O66
|
100mg
|
抗逆转录病毒药物用于治疗艾滋病毒感染
|
|
E588525
|
5’-Epi Lamivudine
|
139757-68-9
|
C8H11N3O3S
|
1/10mg
|
拉米夫定差向异构体标准品
|
|
L172510
|
Lamivudine Triphosphate Ammonium Salt
|
1187058-42-9
|
C8H23N6O12P3S
|
1/10mg
|
拉米夫定代谢物
|
|
L172515
|
Lamivudine Diphosphate Ammonium Salt
|
1187058-41-8
|
C8H19N5O9P2S
|
10mg
|
拉米夫定代谢物
|
|
L172520
|
Lamivudine Monophosphate Ammonium Salt
|
1187058-40-7
|
C8H15N4O6PS
|
1/10mg
|
拉米夫定代谢物
|
|
L172500
|
Lamivudine
|
134678-17-4
|
C8H11N3O3S
|
25mg/250mg/1g
|
拉米夫定分析标准品
|
|
V673002
|
Viramidine-13C5 Hydrochloride
|
|
QQ:1749072012